ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

167 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2016 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.5M
Puts
$21.5M
Net Calls
Net Calls Change

Top Buyers

1 +$21.6M
2 +$12.6M
3 +$11.4M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.62M
5
Goldman Sachs
Goldman Sachs
New York
+$9.02M

Top Sellers

1 -$18.1M
2 -$11.5M
3 -$7.83M
4
Prudential Financial
Prudential Financial
New Jersey
-$7.03M
5
Millennium Management
Millennium Management
New York
-$6.63M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$646K
102
$626K
103
$613K
104
$613K
105
$571K
106
$532K
107
$522K
108
$508K
109
$505K
110
$500K
111
$499K
112
$495K
113
$491K
114
$485K
115
$474K
116
$463K
117
$448K
118
$435K
119
$426K
120
$370K
121
$361K
122
$340K
123
$332K
124
$327K
125
$274K